Protein Sciences specializes in vaccine development and protein production. Our mission is our inspiration: to save lives and improve health by effectively responding to the changing world through the creation of innovative vaccines and biopharmaceuticals.

FluBlok, a recombinant protein-based seasonal influenza vaccine, has shown excellent performance in the clinic. A Biologics License Application (BLA) for approval in adults 18 years and older is under review at the FDA.